XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jul. 31, 2024
Jul. 31, 2023
Jul. 31, 2024
Jul. 31, 2023
Income Statement [Abstract]        
Net sales and revenue $ 148,155 $ 211,977 $ 309,386 $ 424,691
Cost of sales (includes $28,340 and $26,399 with related parties for the three months ended July 31, 2024 and 2023, respectively, and $58,987 and $59,887 with related parties for the six months ended July 31, 2024 and 2023, respectively.) 128,382 193,625 275,162 396,173
Gross profit 19,773 18,352 34,224 28,518
Selling, general and administrative expenses (6,440) (8,618) (12,551) (14,387)
Equity in income of unconsolidated affiliates 1,747 3,047 3,465 4,537
Interest and other income, net 4,416 3,271 10,321 6,072
Income before income taxes 19,496 16,052 35,459 24,740
Provision for income taxes (4,489) (3,768) (8,179) (5,756)
Net income 15,007 12,284 27,280 18,984
Net income attributable to noncontrolling interests (2,629) (3,229) (4,711) (4,693)
Net income attributable to REX common shareholders $ 12,378 $ 9,055 $ 22,569 $ 14,291
Weighted average shares outstanding – basic (in Shares) 17,548 17,460 17,528 17,427
Basic net income per share attributable to REX common shareholders (in Dollars per share) $ 0.71 $ 0.52 $ 1.29 $ 0.82
Weighted average shares outstanding – diluted (in Shares) 17,671 17,460 17,648 17,427
Diluted net income per share attributable to REX common shareholders (in Dollars per share) $ 0.7 $ 0.52 $ 1.28 $ 0.82